Frigate Ventures »

Capricor Therapeutics shares owned by Frigate Ventures

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.0M 68k 28.86

More positions owned by Frigate Ventures

Strategy Option Put Option (MSTR)
Lionsgate Studios Corp Equity (LION)
iShares MSCI Canada ETF Option Put Option (EWC)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Clear Channel Outdoor Holdings Equity (CCO)
Nvidia Corp Equity (NVDA)
Match Group Equity (MTCH)
SPDR S&P 500 ETF Trust Option Put Option (SPY)
New America Acquisition I Corp Equity Unit (NWAX.U)
Five9 Equity (FIVN)
M3-Brigade Acquisition V Corp Equity (MBAV)
FutureCrest Acquisition Corp Equity Unit (FCRS.U)
Blue Water Acquisition Corp III Equity (BLUW)
Texas Ventures Acquisition III Corp Equity (TVA)
Canadian Pacific Kansas City Option Call Option (CP)

View all positions for Frigate Ventures

Top funds holding Capricor Therapeutics

BlackRock
Susquehanna International
Vanguard Group
Point72 Asset Management
Suvretta Capital Management
Tang Capital Management
Citadel Advisors
Geode Capital Management
Caption Management
State Street Corporation
Darwin Global Management
Diadema Partners
Soleus Capital Management
J. Goldman & Co
Ikarian Capital

View all funds holding Capricor Therapeutics